
2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity
Keywords: 2-BFI; Brain-creatine kinase; CaATPase; Calpain; Imidazoline 2 receptor; Experimental autoimmune encephalomyelitis; Multiple sclerosis